diprofos has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, SJ; Liu, M; Liu, SS; Rong, L; Yang, TY; Zhang, JY | 1 |
| Cui, L; Guo, Y; Hong, ZJ; Jiang, HQ; Yuan, SM; Zhang, M | 1 |
2 other study(ies) available for diprofos and Skin Neoplasms
| Article | Year |
|---|---|
Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betamethasone; Drug Combinations; Hemangioma; Humans; Infant; Injections, Intralesional; Skin Neoplasms; Timolol; Treatment Outcome | 2021 |
Intralesional injection of diprospan is effective for infantile hemangioma.
Topics: Betamethasone; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Injections, Intralesional; Male; Propranolol; Remission Induction; Skin Neoplasms; Soft Tissue Neoplasms; Torso; Upper Extremity | 2015 |